Hims & Hers Health Inc SEC Filings

Hims & Hers Health, Inc. (HIMS) filing a Form 144 notifies the proposed sale of 65,110 Class A shares through Fidelity Brokerage Services on 09/17/2025 with an aggregate market value of $3,292,903.57. The shares were acquired by restricted stock vesting on 09/15/2025 and paid as compensation. The filing also lists multiple Class A sales by Andrew Dudum and the Dudum Family Trust during the past three months, including sizable single-month transactions on 07/21/2025, 08/18/2025 and 09/16/2025. The filer certifies they are not aware of any undisclosed material adverse information and provides broker details and seller addresses as required by Rule 144.

Hims & Hers Health, Inc. filing a Form 144 notifies the proposed sale of 2,637 Class A shares by a holder whose shares were acquired on 09/15/2025 through restricted stock vesting and paid as compensation. The filing lists the broker as Fidelity Brokerage Services LLC and an approximate sale date of 09/17/2025, with an aggregate market value of $133,168.50. The issuer's total Class A shares outstanding are stated as 217,641,958, indicating the proposed sale represents a very small fraction of outstanding stock. The filing also discloses six prior Class A sales by the same person between 06/17/2025 and 08/25/2025, each of roughly 2,571–2,572 shares with gross proceeds ranging from $114,486.63 to $153,677.00. The notice includes the standard attestation that the seller is not aware of undisclosed material adverse information.

Hims & Hers Health, Inc. reported a proposed insider sale under Rule 144: 10,021 Class A shares are planned for sale through Fidelity Brokerage, with an aggregate market value of $506,060.50 and an approximate sale date of 09/17/2025 on the NYSE. The shares were acquired by restricted stock vesting from the issuer on 09/15/2025 as compensation.

The filing also discloses a recent disposition by the same person, Patrick H. Carroll, who sold 60,000 Class A shares on 08/06/2025 for gross proceeds of $3,214,880.58. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.

Hims & Hers Health, Inc. (HIMS) Form 144 records an insider notice for the proposed sale of 13,749 Class A shares through Fidelity Brokerage Services with an aggregate market value of $694,324.50, approximately tied to the reported outstanding share count of 217,641,958 shares. The proposed sale date is 09/17/2025. The shares were acquired on 09/15/2025 via restricted stock vesting and were paid as compensation. The filing lists prior Class A sales by the same person, Michael Y. Chi, totaling multiple transactions between June and September 2025 with gross proceeds shown per trade.

Form 144 notice for Hims & Hers Health, Inc. (HIMS) reports a proposed sale of 8,410 Class A shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $424,705.00 and an approximate sale date of 09/17/2025. The shares were acquired on 09/15/2025 upon restricted stock vesting and the consideration is listed as compensation. The filing also discloses a prior sale by Irene Becklund of 8,485 Class A shares on 06/17/2025 for gross proceeds of $506,978.75. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Form 144 filed for Hims & Hers Health, Inc. (HIMS) reporting a proposed sale of Class A common stock. The notice identifies a proposed sale of 175,661 Class A shares through Fidelity Brokerage Services LLC with an aggregate market value of $9,384,625.88 and lists 217,641,958 shares outstanding. The filing shows acquisition dates for the shares to be sold: restricted stock vesting on 03/15/2022, 03/15/2023, 06/15/2023, and 06/15/2024 (totaling listed smaller lots), and an option grant payable in cash on 09/16/2025 for 125,335 shares. The approximate date of sale is 09/16/2025 on the NYSE. The filing also discloses multiple sales by the seller(s) during the past three months with amounts and gross proceeds for each transaction. The form includes the required signature representation about material nonpublic information.

Form 144 filed for Hims & Hers Health, Inc. (HIMS) discloses a proposed sale of 145,000 shares of common stock through Goldman Sachs & Co. LLC on 09/15/2025 with an indicated aggregate market value of $7,824,200. The filing lists the securities to be sold as consisting of previously granted compensation instruments, including multiple restricted stock unit grants dated 06/15/2024, 09/15/2024 and several stock option cashless exercises dated 02/24/2022 through 08/24/2025. The filer also reported a series of sales by Oluyemi Okupe in June–August 2025 (examples: 23,107 shares on 06/23/2025; 11,581 shares on 07/07/2025 and additional July/August trades) with reported gross proceeds for each transaction. The notice includes the required signature representation regarding material nonpublic information.

Form 144 notice by a holder of HIMS Class A shares reports a proposed sale and recent sales activity. The filer intends to sell 4,150 Class A shares through Fidelity Brokerage Services (NYSE) with an aggregate market value of $232,400 and an approximate sale date of 09/15/2025. The securities to be sold were acquired on 09/15/2025 by exercise of options granted on 08/10/2022, 02/24/2022 and 03/01/2023 (1,800; 2,100; and 250 shares respectively) with cash payment. The notice lists five Class A sales by Michael Y. Chi between 06/17/2025 and 08/01/2025 totaling 83,552 shares for gross proceeds of approximately $3,693,196.50. The signer represents no undisclosed material adverse information.

Hims & Hers Health, Inc. disclosed a lease and related guaranty executed on September 1, 2025. The lease has an initial 15-year term with two successive five-year extension options and a Rent Commencement Date of April 1, 2026. The first-year annual base rent is $5,984,204 (about $498,684 per month) and will escalate ~3.25% annually. Base rent is fully abated from the Lease Commencement Date through the day before the Rent Commencement Date, and a monthly abatement of $262,838.42 applies for five months after rent begins. Hims is responsible for operating expenses starting at Rent Commencement. A $5,984,204 letter of credit from JPMorgan Chase secures Hims’ obligations, and the company filed a guaranty of the lease.